Filing metadata

Accession number
0001415889-24-010424
Form type
Form 4
Filer
Kinnate Biopharma Inc.
CIK
CIK 1797768
Filed
Apr 05, 2024
Reporting period
Apr 03, 2024
Description
Insider transaction

Explore SEC Filings Hub